119 related articles for article (PubMed ID: 10477086)
21. Intracerebroventricularly administered corticotropin-releasing factor releases somatostatin through a cholinergic, vagal pathway in freely fed rats.
Smedh U; Uvnäs-Moberg K
Acta Physiol Scand; 1994 Jun; 151(2):241-8. PubMed ID: 7942060
[TBL] [Abstract][Full Text] [Related]
22. Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats.
Gué M; Junien JL; Reeve JR; Rivier J; Grandt D; Taché Y
Br J Pharmacol; 1996 May; 118(2):237-42. PubMed ID: 8735621
[TBL] [Abstract][Full Text] [Related]
23. Peptides of the corticoliberin superfamily attenuate thermal and neurogenic inflammation in rat pawskin.
Wei ET; Kiang JG
Eur J Pharmacol; 1989 Sep; 168(1):81-6. PubMed ID: 2583234
[TBL] [Abstract][Full Text] [Related]
24. Brainstem thyrotropin-releasing hormone regulates food intake through vagal-dependent cholinergic stimulation of ghrelin secretion.
Ao Y; Go VL; Toy N; Li T; Wang Y; Song MK; Reeve JR; Liu Y; Yang H
Endocrinology; 2006 Dec; 147(12):6004-10. PubMed ID: 16959836
[TBL] [Abstract][Full Text] [Related]
25. Neuronal pathways involved in abdominal surgery-induced gastric ileus in rats.
Barquist E; Bonaz B; Martinez V; Rivier J; Zinner MJ; Taché Y
Am J Physiol; 1996 Apr; 270(4 Pt 2):R888-94. PubMed ID: 8967419
[TBL] [Abstract][Full Text] [Related]
26. Effect of central corticotropin releasing factor on hepatic circulation in rats: the role of the CRF2 receptor in the brain.
Yoneda M; Nakamura K; Nakade Y; Tamano M; Kono T; Watanobe H; Shimada T; Hiraishi H; Terano A
Gut; 2005 Feb; 54(2):282-8. PubMed ID: 15647195
[TBL] [Abstract][Full Text] [Related]
27. Intracerebroventricular CRF inhibits cold restraint-induced c-fos expression in the dorsal motor nucleus of the vagus and gastric erosions in rats.
Wang L; Cardin S; Martínez V; Taché Y
Brain Res; 1996 Oct; 736(1-2):44-53. PubMed ID: 8930307
[TBL] [Abstract][Full Text] [Related]
28. Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors.
Facci L; Stevens DA; Pangallo M; Franceschini D; Skaper SD; Strijbos PJ
Neuropharmacology; 2003 Oct; 45(5):623-36. PubMed ID: 12941376
[TBL] [Abstract][Full Text] [Related]
29. Effects of corticotropin releasing factor and sauvagine on social behavior of isolated mice.
Mele A; Cabib S; Oliverio A; Melchiorri P; Puglisi-Allegra S
Peptides; 1987; 8(5):935-8. PubMed ID: 3501578
[TBL] [Abstract][Full Text] [Related]
30. Intravenous glucose infusion decreases intracisternal thyrotropin-releasing hormone induced vagal stimulation of gastric acid secretion in anesthetized rats.
Doong ML; Yang H
Neurosci Lett; 2003 Apr; 340(1):49-52. PubMed ID: 12648756
[TBL] [Abstract][Full Text] [Related]
31. Intracisternal antisense oligodeoxynucleotides to the thyrotropin-releasing hormone receptor blocked vagal-dependent stimulation of gastric emptying induced by acute cold in rats.
Martinez V; Wu SV; Taché Y
Endocrinology; 1998 Sep; 139(9):3730-5. PubMed ID: 9724024
[TBL] [Abstract][Full Text] [Related]
32. Medullary thyrotropin-releasing hormone mediates vagal-dependent adaptive gastric protection induced by mild acid in rats.
Kaneko H; Kato K; Ohning G; Taché Y
Gastroenterology; 1995 Sep; 109(3):861-5. PubMed ID: 7657115
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the biologic actions of corticotropin-releasing factor and sauvagine.
Brown MR; Fisher LA; Spiess J; Rivier J; Rivier C; Vale W
Regul Pept; 1982 Jul; 4(2):107-14. PubMed ID: 6289384
[TBL] [Abstract][Full Text] [Related]
34. Role of CRF receptor 1 in central CRF-induced stimulation of colonic propulsion in rats.
Martínez V; Taché Y
Brain Res; 2001 Mar; 893(1-2):29-35. PubMed ID: 11222989
[TBL] [Abstract][Full Text] [Related]
35. Central action of adrenomedullin to inhibit gastric emptying in rats.
Martínez V; Cuttitta F; Taché Y
Endocrinology; 1997 Sep; 138(9):3749-55. PubMed ID: 9275061
[TBL] [Abstract][Full Text] [Related]
36. Sauvagine: effects on thermoregulation in the rat.
Broccardo M
Pharmacol Res; 1990; 22(2):189-96. PubMed ID: 2330343
[TBL] [Abstract][Full Text] [Related]
37. The dorsal vagal complex as a site for cocaine- and amphetamine-regulated transcript peptide to suppress gastric emptying.
Smedh U; Moran TH
Am J Physiol Regul Integr Comp Physiol; 2006 Jul; 291(1):R124-30. PubMed ID: 16455772
[TBL] [Abstract][Full Text] [Related]
38. Peripheral mediators involved in gastric hyperemia to vagal activation by central TRH analog in rats.
Király A; Sütö G; Guth PH; Taché Y
Am J Physiol; 1998 Jan; 274(1):G170-7. PubMed ID: 9458786
[TBL] [Abstract][Full Text] [Related]
39. Characterization of a novel and potent corticotropin-releasing factor antagonist in rats.
Menzaghi F; Howard RL; Heinrichs SC; Vale W; Rivier J; Koob GF
J Pharmacol Exp Ther; 1994 May; 269(2):564-72. PubMed ID: 8182523
[TBL] [Abstract][Full Text] [Related]
40. Corticotropin-releasing factor type 1 and type 2alpha receptors regulate phosphorylation of calcium/cyclic adenosine 3',5'-monophosphate response element-binding protein and activation of p42/p44 mitogen-activated protein kinase.
Rossant CJ; Pinnock RD; Hughes J; Hall MD; McNulty S
Endocrinology; 1999 Apr; 140(4):1525-36. PubMed ID: 10098484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
